Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

Mesoporous silica nanoparticles (MSNs) are a promising material for drug delivery. In this Full Paper, MSNs are first shown to be well tolerated, as demonstrated by serological, hematological, and histopathological examinations of blood samples and mouse tissues after MSN injection. Biodistribution studies using human cancer xenografts are carried out with in vivo imaging and fluorescent microscopy imaging, as well as with inductively coupled plasma mass spectroscopy. The results show that MSNs preferentially accumulate in tumors. Finally, the drug-delivery capability of MSNs is demonstrated by following tumor growth in mice treated with camptothecin-loaded MSNs. These results indicate that MSNs are biocompatible, preferentially accumulate in tumors, and effectively deliver drugs to the tumors and suppress tumor growth.

[1]  Sha Jin,et al.  Nanoparticle-mediated gene delivery. , 2009, Methods in molecular biology.

[2]  Taeghwan Hyeon,et al.  Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. , 2008, Angewandte Chemie.

[3]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[4]  Valentina Cauda,et al.  Multiple core-shell functionalized colloidal mesoporous silica nanoparticles. , 2009, Journal of the American Chemical Society.

[5]  M. Ullman-Cullere,et al.  Body condition scoring: a rapid and accurate method for assessing health status in mice. , 1999, Laboratory animal science.

[6]  Jeffrey I Zink,et al.  Light-activated nanoimpeller-controlled drug release in cancer cells. , 2008, Small.

[7]  Kemin Wang,et al.  In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. , 2008, Analytical chemistry.

[8]  J. F. Stoddart,et al.  pH clock-operated mechanized nanoparticles. , 2009, Journal of the American Chemical Society.

[9]  Maurizio Pellecchia,et al.  Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes. , 2007, Journal of the American Chemical Society.

[10]  V. S. Lin,et al.  Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. , 2009, Journal of the American Chemical Society.

[11]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[12]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[13]  Rajesh Singh,et al.  Nanoparticle-based targeted drug delivery. , 2009, Experimental and molecular pathology.

[14]  Robert Langer,et al.  The biocompatibility of mesoporous silicates. , 2008, Biomaterials.

[15]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[16]  Niveen M. Khashab,et al.  Light-operated mechanized nanoparticles. , 2009, Journal of the American Chemical Society.

[17]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[18]  F. Tamanoi,et al.  Silica nanoparticles as a delivery system for nucleic acid-based reagents. , 2009, Journal of materials chemistry.

[19]  Victor S-Y Lin,et al.  Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. , 2007, Chemical communications.

[20]  Seong Huh,et al.  Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method , 2003 .

[21]  Monty Liong,et al.  Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery. , 2009, Journal of the American Ceramic Society. American Ceramic Society.

[22]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. , 2008, Small.

[23]  Alex Wagner,et al.  Cooperative acid-base effects with functionalized mesoporous silica nanoparticles: applications in carbon-carbon bond-formation reactions. , 2009, Chemistry.

[24]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[25]  C. Batich,et al.  Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. , 2005, Journal of nanoscience and nanotechnology.

[26]  John J. Schlager,et al.  Toxicity Evaluation for Safe Use of Nanomaterials: Recent Achievements and Technical Challenges , 2009 .

[27]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[28]  Monty Liong,et al.  Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.

[29]  Yuen A. Lau,et al.  Mechanised nanoparticles for drug delivery. , 2009, Nanoscale.

[30]  Douglas J Taatjes,et al.  Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells. , 2007, American journal of respiratory cell and molecular biology.

[31]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. , 2008, Small.

[32]  Cari D. Pentecost,et al.  Construction of a pH-driven supramolecular nanovalve. , 2006, Organic letters.

[33]  T. Bein,et al.  Colloidal suspensions of functionalized mesoporous silica nanoparticles. , 2008, ACS nano.

[34]  E. Chang,et al.  Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. , 2004, Molecular cancer therapeutics.

[35]  Monty Liong,et al.  Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells , 2007, Nanobiotechnology : the journal at the intersection of nanotechnology, molecular biology, and biomedical sciences.

[36]  F M Muggia,et al.  Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Luwei Chen,et al.  Controlled synthesis, characterization, and catalytic properties of Mn(2)O(3) and Mn(3)O(4) nanoparticles supported on mesoporous silica SBA-15. , 2006, The journal of physical chemistry. B.

[38]  Juan L. Vivero-Escoto,et al.  Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. , 2009, Chemical communications.

[39]  Douglas C. Friedman,et al.  pH-responsive mechanised nanoparticles gated by semirotaxanes. , 2009, Chemical communications.

[40]  Saji George,et al.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.

[41]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[42]  J. Steinkamp,et al.  Analysis of fluorescence lifetime and quenching of FITC-conjugated antibodies on cells by phase-sensitive flow cytometry. , 1996, Cytometry.

[43]  Jayanth Panyam,et al.  The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. , 2010, Biomaterials.

[44]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[45]  Michelle Bradbury,et al.  Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. , 2009, Nano letters.

[46]  J. F. Stoddart,et al.  pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. , 2008, Angewandte Chemie.

[47]  K. Tsuchida,et al.  Recent advances in inorganic nanoparticle-based drug delivery systems. , 2008, Mini reviews in medicinal chemistry.

[48]  J. F. Stoddart,et al.  Controlled-access hollow mechanized silica nanocontainers. , 2009, Journal of the American Chemical Society.

[49]  Jinwoo Cheon,et al.  Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.